Global Dermatologicals Market Size, Share, Growth Analysis Report - Forecast 2034

Dermatologicals Market: Industry Perspective

The global dermatologicals market size was worth around USD 24.07 Billion in 2024 and is predicted to grow to around USD 64.86 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 10.42% between 2025 and 2034.

The report analyzes the global dermatologicals market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the dermatologicals industry.

Request Free Sample

Radiodermatitis Market: Overview

The medical specialty known as dermatology is focused on treating skin conditions such as psoriasis, atopic dermatitis, skin cancer, and acne. A dermatologist specializes in diseases of the skin, hair, and nails. According to the American Academy of Dermatology Association, an estimated 3,000 skin-related diseases can be recognized and treated by a dermatologist. The skin is a physical barrier that shields the body's interior organs from infection and damage. Practically everyone can experience the symptoms of one or more dermatological disorders at some point.

Key Insights

• As per the analysis shared by our research analyst, the global dermatologicals market is estimated to grow annually at a CAGR of around 10.42% over the forecast period (2025-2034).
• Regarding revenue, the global dermatologicals market size was valued at around USD 24.07 Billion in 2024 and is projected to reach USD 64.86 Billion by 2034.
• The dermatologicals market is projected to grow at a significant rate due to rising prevalence of skin disorders, aging population, increasing awareness of skincare, and advancements in topical and biologic treatments.
• Based on Product Type, the Corticosteroids segment is expected to lead the global market.
• On the basis of Application, the Acne segment is growing at a high rate and will continue to dominate the global market.
• Based on the Route of Administration, the Topical segment is projected to swipe the largest market share.
• By Distribution Channel, the Hospital Pharmacies segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Dermatological Market: Growth Drivers

An increase in technological advancements to drive market growth

During the forecast period, technological advancement in the pharmaceutical sector to produce innovative dermatological products is anticipated to offer lucrative prospects for expanding the global dermatological market. The existence of important manufacturing firms that produce & distribute dermatological products and rising healthcare spending also contribute to the market's expansion.

Dermatological Market: Restraints

The alternative treatments available for acne hamper market expansion

People who have acne frequently use complementary or alternative medicine. Gels, creams, lotions, herbal supplements, dietary regimens unique to you, and dietary supplements are a few examples. Alternative methods for treating acne are highly regarded. However, "all-natural supplements" have not been proven beneficial, and some may even be dangerous, according to the American Academy of Dermatology (AAD). The group mentions an over-the-counter (OTC) acne supplement as an illustration, which included more than 200 times the recommended dosage of selenium. It resulted in a variety of harmful effects.

Dermatological Market: Opportunity

Significant pharmaceutical expansion to generate investment opportunities

The growth of the pharmaceutical industry is an opportunity for the global dermatological market. Additionally, a rise in the quantity of clinical research greatly impacts market expansion. Clinical research aims to assess the effectiveness and safety of dermatological products. The increase in dermatological product approvals is one of the major factors propelling the global market. For instance, the biopharmaceutical company Amgen announced in December 2021 that the Food and Drug Administration (FDA) had approved Otezla (apremilast), which is advised to treat people with plaque psoriasis.

Request Free Sample

Dermatological Market: Segmentation

The global dermatological market has been segmented into disease and distribution channels.

Based on disease, the market is classified into acne, dermatitis, psoriasis, skin cancer, rosacea, alopecia, and others. In 2021, the acne category dominated the global market. Due to improvements in healthcare R&D activities and increased acne incidence, the acne capsules category dominated the dermatological market. This trend is anticipated to continue over the forecast period. However, due to an increase in demand for dermatitis, the dermatitis segment is anticipated to experience significant growth throughout the projection period.

Based on the type channel, the global dermatological market is segmented into prescription and over-the-counter drugs. Due to the rising prevalence of skin illnesses and activities taken by public and private organizations to address skin disease, the prescription-based pharmaceuticals segment was the largest contributor and is anticipated to continue its lead throughout the forecast period. However, the over-the-counter pharmaceuticals segment is anticipated to experience significant growth during the projected period due to rising over-the-counter drug demand and increasing the number of over-the-counter drug approvals.

Based on the route of administration, the market is classified into topical administration, oral administration, and parenteral administration. The dermatological market was dominated by the topical administration segment. This trend is anticipated to persist throughout the forecast period due to rising topical administration demand, an increase in the number of drugs receiving U.S. FDA approval, and improvements in R&D activities in the pharmaceutical industry. However, due to technological advancements in the healthcare industry and an increase in biologic pharmaceuticals, the parenteral administration segment is anticipated to have significant growth over the forecast period.

Dermatologicals Market: Report Scope

Recent Developments

• January 2020: Eli Lilly & Company struck a legally binding agreement to add late-stage and commercial pharmaceuticals to its portfolio by paying USD 1.1 billion in cash for the dermatological drug developer Dermira.
• December 2019: Psoriatic arthritis (PsA), chronic severe plaque psoriasis (PsO), and other indications were treated with AVSOLA (infliximab-axxq), which Amgen Inc. got FDA approval for it.
• December 2019: In a similar vein, Bausch Health Companies Inc. got FDA approval for ARAZLOTM (tazarotene) Lotion, 0.045 percent, for the topical treatment of acne vulgaris. Therefore, it is anticipated that these reasons will greatly increase the market for dermatological therapies in the North American continent.

Dermatologicals Market: Regional Analysis

North America is the fastest-growing region in the dermatological market in 2034

Due to the rise in the prevalence of acne, the rise in the number of dermatological products receiving approval, the presence of key players, and the development of R&D activities in the healthcare sector in the region, North America captured a significant portion of the market for dermatological and is anticipated to maintain its dominance during the forecast period.

Asia Pacific is anticipated to see the highest CAGR in the global dermatological market. The most populous nations globally, such as China and India, are anticipated to have many skin disease sufferers during the projection period. The highest growth in this market is attributed to factors such as health services, life science industry advancements, and increased awareness of skin conditions and their treatments. Additionally, this industry is expanding at a fast rate due to rising incomes and consumer power.

Dermatologicals Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the dermatologicals market on a global and regional basis.

The global dermatologicals market is dominated by players like:

• AbbVie
• Amgen
• Galderma
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
• Eli Lilly
• Sun Pharmaceutical Industries
• Almirall
• Bausch Health

The global dermatologicals market is segmented as follows;

By Product Type

• Corticosteroids
• Anti-infectives
• Calcineurin Inhibitors
• Retinoids
• Others

By Application

• Acne
• Psoriasis
• Eczema
• Rosacea
• Others

By Route of Administration

• Topical
• Oral
• Parenteral

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America